| Name: | iberis amara l. extract |
| CAS Number: | 91745-90-3 |
|
| ECHA EC Number: | 294-761-8 |
| FDA UNII: | Search |
Category:information only not used for fragrances or flavors
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Food Chemicals Codex Listed: | No |
Organoleptic Properties:
| Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | | information only not used for fragrances or flavors |
| Recommendation for iberis amara extract usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for iberis amara extract flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
| | iberis amara l. extract |
| Pubchem (sid): | 135356894 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
Articles:
| PubMed:Phytotherapy of chronic abdominal pain following pancreatic carcinoma surgery: a single case observation. |
| PubMed:Corolla monosymmetry: evolution of a morphological novelty in the Brassicaceae family. |
| PubMed:Kaempferol-3,4'-di-O-beta-glucopyranoside-7-O-alpha-rhamnopyranoside as a new flavonoid from Iberis amara L. |
| PubMed:Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6. |
| PubMed:Control of corolla monosymmetry in the Brassicaceae Iberis amara. |
| PubMed:STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. |
| PubMed:Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle. |
| PubMed:Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors. |
| PubMed:Pharmaceutical prerequisites for a multi-target therapy. |
| PubMed:Iberis amara L. and Iberogast--results of a systematic review concerning functional dyspepsia. |
| PubMed:Herbal extracts modulate the amplitude and frequency of slow waves in circular smooth muscle of mouse small intestine. |
| PubMed:Comparison of the inhibition of myeloperoxidase-catalyzed hypochlorite formation in vitro and in whole blood by different plant extracts contained in a phytopharmacon treating functional dyspepsia. |
| PubMed:Orientation and feeding responses of the pollen beetle, Meligethes aeneus, to candytuft, Iberis amara. |
| PubMed:Antioxidative properties of Iberis amara extracts in biochemical model reactions. |
| PubMed:[Drugs with Iberis amara as a modern phytotherapy to treat chronic functional disorders of the gastrointestinal tract]. |
| PubMed:[Iberis amara L. (bitter candytuft)--profile of a medicinal plant]. |
| PubMed:[Iberogast: a modern phytotherapeutic combined herbal drug for the treatment of functional disorders of the gastrointestinal tract (dyspepsia, irritable bowel syndrome)--from phytomedicine to "evidence based phytotherapy." A systematic review]. |
| PubMed:Evaluation of glucoiberin reference material from Iberis amara by spectroscopic fingerprinting. |
| PubMed:[Dyspeptic pain and phytotherapy--a review of traditional and modern herbal drugs]. |
| PubMed:Antiulcerogenic effect of some gastrointestinally acting plant extracts and their combination. |
| PubMed:An antioxidant sinapic acid ester isolated from Iberis amara. |
| PubMed:Cucurbitacins: differential cytotoxicity, dereplication and first isolation from Gonystylus keithii. |
| PubMed:Oviposition stimulants and deterrents regulating differential acceptance ofIberis amara byPieris rapae andP. napi oleracea. |
| PubMed:Immunochemical and chemical investigations of the structure of glycoprotein fragments obtained from epiglycanin, a glycoprotein at the surface of the TA3-Ha cancer cell. |
| PubMed:Further characterization of some heterophile agglutinins reacting with alkali-labile carbohydrate chains of human erythrocyte glycoproteins. |
| PubMed:[Flavonoid compounds in the blossoms of Iberis amara L]. |
| PubMed:Studies on lectins with a broad agglutination spectrum. XII. N-acetyl-D-galactosamine specific lectins from the seeds of Soja hispida, Bauhinia purpurea, Iberis amara, Moluccella laevis and Vicia graminea. |
| PubMed:[Cucurbitacins as stathmokinetic agents]. |
| PubMed:[THE DISTRIBUTION OF CUCURBITACINS AND CUCURBITACIN GLYCOSIDES IN THE GENUS IBERIS (CRUCIFERAE). ISOLATION OF CUCURBITACINS J AND K FROM IBERIS AMARA L. AND CUCURBITACIN B AND FROM IBERIS UMBELLATA L]. |
| PubMed:[Iberis amara and the significance of homeotherapeutic symptomatology in cardiacs]. |
| PubMed:[Mustard oil glycoside glucoiberine and bitter principle ibamarine of Iberis amara L. (candytuft). IX. Mustard oil glycoside]. |
|